Summary
Early postoperative epilepsy is a frequent complication of supratentorial intracranial surgery. The lack of consensus on prophylaxis of early postoperative seizures with phenytoin (PHT) may be due to the different dosages used in several studies, owing to inadequate therapeutic plasma level.
The aim of this study was to evaluate which dosage of PHT can maintain the therapeutic range in the early postoperative period.
Twenty patients operated on for supratentorial neoplasms were randomly allocated to receive, during the last hour of the surgical procedure, loading doses of either 10 mg/kg (group A, n = 10) or 15 mg/kg (group B, n = 10) of PHT. PHT infusion rate never exceeded 30 mg/min. Six hours after the loading dose, PHT maintenance treatment (250 mg, i.V., every 8 hours) was started in all patients. PHT plasma levels were evaluated from the end of the intra-operative loading infusion up to 24 h.
During the first six hours after the loading dose, phenytoin plasma levels fell below the therapeutic range (10–20 mg/1) in 7 out of the 10 patients receiving 10 mg/kg, while in the patients treated with 15 mg/kg, PHT plasma levels were always in the therapeutic range (P ⩽ 0.0001). PHT maintenance dose was sufficient to keep plasma levels within the therapeutic range in 8 patients in group A, and in all the patients in group B.
It is concluded that a loading dose of 15 mg/kg, followed by postoperative treatment, is necessary to guarantee therapeutic plasma levels of phenytoin in the immediate postoperative period, when seizure risk is very high.
Similar content being viewed by others
References
Aronson JK, Hardman M, Reynolds DJM (1992) Phenytoin. BMJ 305: 1215–1218
Boarini DJ, Beck DW, Vangilder JC (1985) Postoperative prophylactic anticonvulsivant therapy in cerebral gliomas. Neurosurgery 16: 290–292
Deutschman CS, Haines SJ (1985) Anticonvulsant prophylaxis in neurological surgery. Neurosurgery 17: 510–517
Foy PM, Chadwick DW, Rajgopalan N, Johnson AL, Shaw MDM (1992) Do prophylactic anticonvulsivant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry 55: 753–757
Franceschetti S, Binelli S, Casazza M, Lodrini S, Panzica F, Pluchino F, Solero CL, Avanzini G (1990) Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta Neurochir (Wien) 103: 47–51
Karlsson E, Sonnhag S (1976) Haemodynamic effects of procainamide and phenytoin at apparent therapeutic plasma levels. Eur J Clin Pharmacol 10: 305–310
Kvam DA, Loftus DM, Copeland B, Quest DO (1983) Seizures during the immediate postoperative period. Neurosurgery 12: 14–17
Lee ST, Lui TN, Chang CN, Cheng WC, Wang DJ, Heimburger RG, Lin CG (1989) Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures. Surg Neurol 31: 361–364
Levati A, Savoia G, Ranzini L, d'Angelo V, Boselli L (1992) Epilessia precoce nella chirurgia delle neoplasie extrassiali sopratentoriali. Min Anestesiol 58 [Suppl 1]: 149–153
Lund L (1974) Anticonvulsant effect of diphenylhydantoin relative to plasma level. Arch Neurol 31: 289–294
Mahaley MS Jr, Dudka L (1981) The role of anticonvulsant medications in the management of patients with anaplastic gliomas. Surg Neurol 16: 399–401
Mixter CG, Moran JM, Austin WG (1966) Cardiac and peripheral vascular effects of diphenylhydantoin sodium. Am J Card 17: 332–338
Newberg Milde L, McDonald MG (1989) Therapeutic loading dose of phenytoin in anesthetized patients. J Neurosurg Anesthesiol 1: 73–75
North BJ, Penjall RK, Hanieh A, Frewin DB, Taylor WB (1983) Phenytoin and postoperative epilepsy. A double blind study. J Neurosurg 58: 672–677
O'Laoire SA (1990) Epilepsy following neurosurgical intervention. Acta Neurochir (Wien) [Suppl] 50: 52–54
Olonow CW, Finn AL (1981) Phenytoin: pharmacokinetics and clinical therapeutics. Neurosurgery 8: 112–117
Plaa GL (1975) Acute toxicity of antiepileptic drugs. Epilepsia 16: 183–191
Rall TW, Schleifer LS (1990) Drugs effective in the therapy of the epilepsies. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon, New York, pp 436–462
Reynolds EH (1978) Drug treatment of epilepsy. Lancet 30: 721–725
Sbeih I, Tamas LB, O'Laoire SA (1986) Epilepsy after operation for aneurisms. Neursosurgery 19: 784–788
Shaw MDM (1990) Postoperative epilepsy and the efficacy of anticonvulsion therapy. Acta Neurochir (Wien) [Suppl] 50: 55–57
Temkin NR, Diikmen SS, Wilensky AJ, Khein J, Chabal S, Winn R (1990) A randomized, double-blind study of phenytoin for the prevention of the post-traumatic seizures. N Engl J Med 323: 497–502
Tsolaki M, Yannacou-Peftoulidou M, Grammaticos PH, Sofianos E, Foroglou G (1987) Phenytoin plasma levels after intraoperative administration of the prevention of post-craniotomy seizures. Acta Neurochir (Wien) 84: 36–38
Wilder BJ (1983) Efficacy of phenytoin in treatment of status epilepticus. Advances in neurology, vol 34: Status epilepticus. Raven, New York, pp 441–445
Zoneraich S, Zoneraich O, Sjegel J (1976) Sudden death following intravenous sodium diphenylhydantoin. Am Heart J 91: 375–377
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levati, A., Savoia, G., Zoppi, F. et al. Peri-operative prophylaxis with phenytoin: Dosage and therapeutic plasma levels. Acta neurochir 138, 274–279 (1996). https://doi.org/10.1007/BF01411737
Issue Date:
DOI: https://doi.org/10.1007/BF01411737